Clinicopathologic Characteristics and Survival Outcomes in Floor of Mouth Squamous Cell Carcinoma: A Population-Based Study
- PMID: 29436280
- DOI: 10.1177/0194599818756815
Clinicopathologic Characteristics and Survival Outcomes in Floor of Mouth Squamous Cell Carcinoma: A Population-Based Study
Abstract
Objective To describe the determinants of survival for patients with floor of mouth (FOM) squamous cell carcinoma (SCC) from 1973 to 2013 with the SEER database (Surveillance, Epidemiology, and End Results). Study Design and Setting Retrospective cohort study with a national database. Subjects and Methods The SEER registry was utilized to calculate survival trends for patients with FOM SCC between 1973 and 2013. Patient data were analyzed with respect to age, sex, race, primary site, stage at presentation, tumor size, grade, and treatment modalities (surgery and radiotherapy). Overall survival (OS) and disease-specific survival (DSS) were calculated. Results A total of 14,010 FOM SCC cases were identified. The cohort was 69.5% male, and the median age at diagnosis was 62 years. Forty-six percent of cases were treated with surgery, while 14% received radiotherapy. Kaplan-Meier analysis demonstrated OS and DSS of 39% and 59% at 5 years, respectively. Multivariate analysis showed that age, grade, stage, size, and surgery were determinants for OS and DSS (all P < .05). For early- and advanced-stage cancers, age, grade, size, and surgery predicted OS and DSS, while radiotherapy was a predictor of OS and DSS in advanced-stage tumors only (all P < .05). Conclusion To our knowledge, this study is the largest to date investigating prognostic factors for survival of patients diagnosed with FOM SCC. Determinants of survival include age, grade, stage, size, and surgery. Surgery appears to play a critical role in the management of these tumors.
Keywords: floor of mouth cancer; head and neck cancer; population-based study; squamous cell carcinoma.
Similar articles
-
Treatment outcomes of patients with primary squamous cell carcinoma of the retromolar trigone.Laryngoscope. 2018 Dec;128(12):2740-2744. doi: 10.1002/lary.27234. Epub 2018 May 14. Laryngoscope. 2018. PMID: 29756295
-
Treatment-related determinants of survival in early-stage (T1-2N0M0) oral cavity cancer: A population-based study.Head Neck. 2017 May;39(5):876-880. doi: 10.1002/hed.24679. Epub 2017 Feb 25. Head Neck. 2017. PMID: 28236368
-
Lymph node ratio as prognosticator in floor of mouth squamous cell carcinoma patients.J Craniomaxillofac Surg. 2018 Feb;46(2):195-200. doi: 10.1016/j.jcms.2017.11.021. Epub 2017 Nov 26. J Craniomaxillofac Surg. 2018. PMID: 29249633
-
Supraglottic Squamous Cell Carcinoma: A Population-Based Study of 22,675 Cases.Laryngoscope. 2019 Aug;129(8):1822-1827. doi: 10.1002/lary.27592. Epub 2018 Dec 11. Laryngoscope. 2019. PMID: 30536822 Review.
-
Results of postoperative interstitial brachytherapy of resectable floor of mouth tumors.Brachytherapy. 2021 Mar-Apr;20(2):376-382. doi: 10.1016/j.brachy.2020.10.008. Epub 2020 Nov 26. Brachytherapy. 2021. PMID: 33250304 Review.
Cited by
-
Prognostic Value of Hematological Parameters in Oral Squamous Cell Carcinoma.Cancers (Basel). 2023 Oct 31;15(21):5245. doi: 10.3390/cancers15215245. Cancers (Basel). 2023. PMID: 37958419 Free PMC article.
-
Floor of Mouth Squamous Cell Carcinoma Presenting as an Abscess.Indian J Otolaryngol Head Neck Surg. 2023 Jun;75(2):902-904. doi: 10.1007/s12070-022-03128-8. Epub 2022 Aug 6. Indian J Otolaryngol Head Neck Surg. 2023. PMID: 37274978
-
A nomogram for predicting overall survival of patients with squamous cell carcinoma of the floor of the mouth: a population-based study.Eur Arch Otorhinolaryngol. 2023 Aug;280(8):3867-3875. doi: 10.1007/s00405-023-07971-5. Epub 2023 Apr 18. Eur Arch Otorhinolaryngol. 2023. PMID: 37071145
-
What is the frequency of floor of the mouth lesions? A descritive study of 4,016 cases.Med Oral Patol Oral Cir Bucal. 2021 Nov 1;26(6):e738-e747. doi: 10.4317/medoral.24537. Med Oral Patol Oral Cir Bucal. 2021. PMID: 34704985 Free PMC article.
-
Dose escalation in advanced floor of the mouth cancer: a pilot study using a combination of IMRT and stereotactic boost.Radiat Oncol. 2021 Jun 29;16(1):122. doi: 10.1186/s13014-021-01842-1. Radiat Oncol. 2021. PMID: 34187494 Free PMC article. Clinical Trial.
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
